Pursuit Vascular, Inc. is focused on preventing costly and deadly catheter-related infections.
Catheter Infections - A Deadly and Costly Problem
The Centers for Disease Control has identified catheter-related blood stream infections (CRBSI) as one of its seven major healthcare challenges; with mortality rates up to 25% and economic costs in the billions of dollars. In the US alone, nearly 500,000 new cases of CRBSI are reported each year, with costs exceeding $3 billion. The need for improvement is compelling and urgent.
ClearGuard™ - A Promising Solution
Pursuit Vascular has developed a novel platform technology intended to safely and effectivily reduce CRBSI in long-term catheters.